TA-NIC
Cat# : THP-0192
| Cat#: |
THP-0192 |
| Product Name: |
TA-NIC |
| Description: |
TA-NIC is an immunotherapeutic vaccine antigen similar in concept to TA-CD, designed to raise anti-nicotine antibodies. |
| Sequences: |
Not Available |
| Molecular Weight: |
515.703 Da |
| Cas No: |
Not Available |
| Formula: |
C26H45NO7S |
| Endotoxin Level: |
<0.001 EU per 1 μg of the peptide by the LAL method |
| Drug Name: |
TA-NIC |
| Applications: |
Investigated for use/treatment in tobacco dependence. |
| Examples of Clinical Use: |
Tobacco dependence |
| Pharmacodynamics: |
Raises anti-nicotine antibodies. The antibodies bind to nicotine molecules in the patient's blood stream, reducing the rate and quantity of nicotine entry into the brain and thus reducing the positive reinforcement and addiction associated with nicotine and cigarette smoking. It is expected that the reduction of the positive reinforcement will in turn reduce the desire to smoke or use other tobacco products. Preliminary trials have supported this supposition. |
| Mechanism of action: |
Reduces nicotine entry into the brain and thus the positive reinforcement associated with smoking. |
| Affected organisms: |
Not Available |
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products
without prior written approval from Creative BioMart.
